Article Versions Notes

Zang PD, Da Silva DM, Liu Z-X, Kandukuri S, Tsao-Wei D, D’Souza A, Kast WM, Pal SK, Kefauver C, Juanqueira M, et al. Immune Modulation During Treatment with Enzalutamide Alone or with Radium-223 in Patients with Castration Resistant Prostate Cancer. Cancers. 2025; 17(10):1730. https://doi.org/10.3390/cancers17101730

Zang, Peter D., Diane M. Da Silva, Zhang-Xu Liu, Shivani Kandukuri, Denice Tsao-Wei, Anishka D’Souza, W. Martin Kast, Sumanta K. Pal, Cheryl Kefauver, Maribel Juanqueira, and et al. 2025. "Immune Modulation During Treatment with Enzalutamide Alone or with Radium-223 in Patients with Castration Resistant Prostate Cancer" Cancers 17, no. 10: 1730. https://doi.org/10.3390/cancers17101730

Zang, P. D., Da Silva, D. M., Liu, Z.-X., Kandukuri, S., Tsao-Wei, D., D’Souza, A., Kast, W. M., Pal, S. K., Kefauver, C., Juanqueira, M., Yang, L., Quinn, D. I., & Dorff, T. B. (2025). Immune Modulation During Treatment with Enzalutamide Alone or with Radium-223 in Patients with Castration Resistant Prostate Cancer. Cancers, 17(10), 1730. https://doi.org/10.3390/cancers17101730